Apoptosis and muscle fibre loss in neuromuscular disorders

D S Tews1

  • 1Neurologisches Edinger-Institut, Johann-Wolfgang Goethe-University Medical Center, Deutschordenstrasse 46, D-60528, Frankfurt, Germany.

Insights

Apoptotic cell death contributes to muscle fiber loss in neuromuscular disorders. Targeting apoptosis pathways offers potential therapeutic strategies for these conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Neuromuscular Disorders

Background:

  • Apoptotic cell death mechanisms, alongside necrosis, are increasingly recognized as contributors to muscle fiber loss.
  • This phenomenon is observed in various neuromuscular conditions, including muscular dystrophies, metabolic myopathies, and denervation injuries.

Purpose of the Study:

  • To elucidate the role of apoptosis in muscle fiber loss in neuromuscular disorders.
  • To identify key molecular effectors and triggers of apoptosis in affected muscle fibers.
  • To explore the therapeutic potential of targeting apoptosis in these conditions.

Main Methods:

  • Analysis of gene expression, specifically focusing on members of the bcl-2 family (e.g., bax, bcl-2).
  • Investigation of mitochondrial membrane permeability transition pores and caspase activation.
  • Morphological and biochemical assessment of apoptotic features, including DNA fragmentation.

Main Results:

  • Up-regulation of bax and bcl-2 suggests their involvement in apoptotic pathways.
  • Mitochondrial permeability transition and caspase activation are identified as key effectors.
  • Apoptotic degradation of nuclei and contractile elements leads to localized muscle fiber atrophy and loss.

Conclusions:

  • Apoptosis is a significant mechanism underlying muscle fiber loss in neuromuscular disorders.
  • Homeostatic dysregulation and oxidative stress, including free radicals and nitric oxide, are identified as essential triggers.
  • Interventions targeting muscle fiber apoptosis present promising therapeutic avenues in the absence of effective primary treatments.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...